Obesity: Health Services
(asked on 16th March 2023) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to help tackle obesity in adults.
This question was answered on 20th March 2023
In addition to the answer I gave the hon. Member on 27 February 2023 to Question 151337, the weight loss drug Semaglutide (Wegovy) will be available on the National Health Service within three months of its launch in the United Kingdom with eligibility in line with National Institute for Health and Care Excellence recommendations to ensure clinically and cost effective use.